<?xml version="1.0" encoding="UTF-8"?><template xmlns="openEHR/v1/Template" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><id>c01c1b9a-f649-4e23-a44d-47647929d844</id><name>PHARM INV FIANLIMAB-CEMIPLIMAB 1600 MG-350 MG OR FIANLIMAB-CEMIPLIMAB 400MG-350 MG OR CEMIPLIMAB 350 MG OR PEMBROLIZUMAB 200 MG IN NACL 0.9 Percent 100 ML B [730161] Order</name><description><lifecycle_state>Initial</lifecycle_state><details><purpose/><use/><misuse/></details><other_details><item><key>MetaDataSet:Sample Set </key><value>Template metadata sample set </value></item><item><key>Acknowledgements</key><value/></item><item><key>Business Process Level</key><value/></item><item><key>Care setting</key><value/></item><item><key>Client group</key><value/></item><item><key>Clinical Record Element</key><value/></item><item><key>Copyright</key><value/></item><item><key>Issues</key><value/></item><item><key>Owner</key><value/></item><item><key>Sign off</key><value/></item><item><key>Speciality</key><value/></item><item><key>User roles</key><value/></item></other_details></description><annotations path="[openEHR-EHR-INSTRUCTION.service_request.v1]"><items><item><key>Technical.EPIC ID</key><value>&lt;p&gt;ERX730161&lt;/p&gt;</value></item><item><key>Catalogue Pattern.Synonyms</key><value>
						&lt;p&gt;
						RESEARCH&lt;br&gt;
								STUDY&lt;br&gt;
								INVESTIGATIONAL
						&lt;/p&gt;
					</value></item><item><key>Pharmacy.Allowed Routes</key><value>
						&lt;p&gt;
						intravenous&lt;br&gt;
								other - see admin instructions
						&lt;/p&gt;
					</value></item><item><key>Technical.ï»© Technical Traceability</key><value>{~AHSID~c01c1b9a-f649-4e23-a44d-47647929d844~NAME~PHARM INV FIANLIMAB-CEMIPLIMAB 1600 MG-350 MG OR FIANLIMAB-CEMIPLIMAB 400MG-350 MG OR CEMIPLIMAB 350 MG OR PEMBROLIZUMAB 200 MG IN NACL 0.9 Percent 100 ML B [730161] Order}</value></item></items></annotations><definition xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" concept_name="Service request" max="1" name="INV fianlimab-cemiplimab 1600 mg-350 mg OR fianlimab-cemiplimab 400 mg-350 mg OR cemiplimab 350 mg OR pembrolizumab 200 mg in NaCl 0.9% 100 mL bag / R3767-ONC-2011 (Trial supply)"/><integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1"><digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest></integrity_checks></template>